SEC Form 4 · accession 0001179110-15-000375
KYTHERA BIOPHARMACEUTICALS INC · KYTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hollings Renton
Director
Period of report
Dec 31, 2014
Accepted (ET)
Jan 5, 2015 · 7:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001436304
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $34.68 | Dec 31, 2014 | A | 18,000 | A | — | Dec 31, 2024 | Common Stock | 18,000 | 18,000 | D |
Explanation of responses
- F1The shares subject to the option will vest in equal monthly installments measured from December 31, 2014 (the "Grant Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Grant Date, subject to continued service through each vesting date.